Search

everythinglearnresearchcommunity

for

Search:↓

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

Oral cyclosporin doesn't stop hair loss.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

AGA progression involves increased lipid synthesis, electron transport, and hair follicle miniaturization.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Dutasteride and finasteride affect different cell types differently.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Warts in HIV-positive men can have serious abnormal cell growth, needing careful analysis and treatment to prevent cancer.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.